RNA interference in vitro and in vivo using DsiRNA targeting the nucleocapsid N mRNA of human metapneumovirus

Antiviral Research

Volumn 93, Issue 3, 2012, Pages 364-373

  Darniot, Magali ^a   Schildgen, Verena ^b,e   Schildgen, Oliver ^b,e   Sproat, Brian ^c,f   Kleines, Michael ^d   Ditt, Vanessa ^b,e   Pitoiset, Cécile ^a   Pothier, Pierre ^a   Manoha, Catherine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF BONN   (Germany)

^c INTEGRATED DNA TECHNOLOGIES   (United States)

^d Division of Virology   (Austria)

^e KRANKENHAUS MERHEIM   (Germany)

^f Chemconsilium GCV ^*  (Belgium)

Author keywords

Metapneumovirus; Mice; RACE; RNA interference; SiRNA

Indexed keywords

DICER SUBSTRATE SMALL INTERFERING RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN METAPNEUMOVIRUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SEQUENCE; VIRUS GENE; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CELL LINE; FEMALE; HUMANS; METAPNEUMOVIRUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PARAMYXOVIRIDAE INFECTIONS; RIBONUCLEASE III; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRAL PROTEINS;

HUMAN METAPNEUMOVIRUS; METAPNEUMOVIRUS; MURINAE; MUS;

EID: 84857934582     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.01.004     Document Type: Article

References (55)

1. Alvarez R., Elbashir S., Borland T., Toudjarska I., Hadwiger P., John M., Roehl I., Morskaya S.S., Martinello R., Kahn J., Van Ranst M., Tripp R.A., DeVincenzo J.P., Pandey R., Maier M., Nechev L., Manoharan M., Kotelianski V., Meyers R. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob. Agents Chemother. 2009, 53:3952-3962.
2. Bastien N., Ward D., Van Caeseele P., Brandt K., Lee S.H., McNabb G., Klisko B., Chan E., Li Y. Human metapneumovirus infection in the Canadian population. J. Clin. Microbiol. 2003, 41:4642-4646.
3. Bartlett D.W., Davis M.E. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 2006, 34:322-333.
4. Behlke M.A. Chemical modification of siRNAs for in vivo use. Oligonucleotides 2008, 18:305-319.
5. Bitko V., Barik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 2001, 1:34.
6. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 2005, 11:50-55.
7. Boivin G., Abed Y., Pelletier G., Ruel L., Moisan D., Cote S., Peret T.C., Erdman D.D., Anderson L.J. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 2002, 186:1330-1334.
8. Bonney D., Razali H., Turner A., Will A. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. Br. J. Haematol. 2009, 145:667-669.
9. Bowden D.H. Cell turnover in the lung. Am. Rev. Respir. Dis. 1983, 128:S46-48.
10. Bramsen J.B., Pakula M.M., Hansen T.B., Bus C., Langkjaer N., Odadzic D., Smicius R., Wengel S.L., Chattopadhyaya J., Engels J.W., Herdewijn P., Wengel J., Kjems J. A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res. 2010, 38:5761-5773.
11. Collingwood M.A., Rose S.D., Huang L., Hillier C., Amarzguioui M., Wiiger M.T., Soifer H.S., Rossi J.J., Behlke M.A. Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs. Oligonucleotides 2008, 18:187-200.
12. Darniot M., Petrella T., Aho S., Pothier P., Manoha C. Immune response and alteration of pulmonary function after primary human metapneumovirus hMPV infection of BALB/c mice. Vaccine 2005, 23:4473-4480.
13. Darniot M., Pitoiset C., Petrella T., Aho S., Pothier P., Manoha C. Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J. Virol. 2009, 83:3323-3332.
14. Deffrasnes C., Cavanagh M.H., Goyette N., Cui K., Ge Q., Seth S., Templin M.V., Quay S.C., Johnson P.H., Boivin G. Inhibition of human metapneumovirus replication by small interfering RNA. Antivir. Ther. 2008, 13:821-832.
15. DeVincenzo J., Lambkin-Williams R., Wilkinson T., Cehelsky J., Nochur S., Walsh E., Meyers R., Gollob J., Vaishnaw A. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc. Natl. Acad. Sci. U S A 2010, 107:8800-8805.
16. Dorsett Y., Tuschl T. SiRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 2004, 3:318-329.
17. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001, 15:188-200.
18. El Saleeby C.M., Bush A.J., Harrison L.M., Aitken J.A., Devincenzo J.P. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J. Infect. Dis. 2011, 204:996-1002.
19. Ferreira H.L., Spilki F.R., de Almeida R.S., Santos M.M., Arns C.W. Inhibition of avian metapneumovirus AMPV replication by RNA interference targeting nucleoprotein gene N in cultured cells. Antiviral Res. 2007, 74:77-81.
20. Frank-Kamenetsky M., Grefhorst A., Anderson N.N., Racie T.S., Bramlage B., Akinc A., Butler D., Charisse K., Dorkin R., Fan Y., Gamba-Vitalo C., Hadwiger P., Jayaraman M., John M., Jayaprakash K.N., Maier M., Nechev L., Rajeev K.G., Read T., Rohl I., Soutschek J., Tan P., Wong J., Wang G., Zimmermann T., de Fougerolles A., Vornlocher H.P., Langer R., Anderson D.G., Manoharan M., Koteliansky V., Horton J.D., Fitzgerald K. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl. Acad. Sci. U S A 2008, 105:11915-11920.
21. Fromont-Racine M., Bertrand E., Pictet R., Grange T. A highly sensitive method for mapping the 5' termini of mRNAs. Nucleic Acids Res. 1993, 21:1683-1684.
22. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. U S A 2003, 100:2718-2723.
23. Hamelmann E., Vella A.T., Oshiba A., Kappler J.W., Marrack P., Gelfand E.W. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc. Natl. Acad. Sci. U S A 1997, 94:1350-1355.
24. Hannon G.J. RNA interference. Nature 2002, 418:244-251.
25. Herfst S., de Graaf M., Schickli J.H., Tang R.S., Kaur J., Yang C.F., Spaete R.R., Haller A.A., van den Hoogen B.G., Osterhaus A.D., Fouchier R.A. Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. J. Virol. 2004, 78:8264-8270.
26. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., Endres S., Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005, 11:263-270.
27. Huang H., Qiao R., Zhao D., Zhang T., Li Y., Yi F., Lai F., Hong J., Ding X., Yang Z., Zhang L., Du Q., Liang Z. Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs. Nucleic Acids Res. 2009, 37:7560-7569.
28. Judge A.D., Robbins M., Tavakoli I., Levi J., Hu L., Fronda A., Ambegia E., McClintock K., MacLachlan I. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J. Clin. Invest. 2009, 119:661-673.
29. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 2005, 23:457-462.
30. Kim D.H., Longo M., Han Y., Lundberg P., Cantin E., Rossi J.J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 2004, 22:321-325.
31. Kim D.H., Behlke M.A., Rose S.D., Chang M.S., Choi S., Rossi J.J. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 2005, 23:222-226.
32. Lee Y.S., Nakahara K., Pham J.W., Kim K., He Z., Sontheimer E.J., Carthew R.W. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004, 117:69-81.
33. Lüsebrink J., Wiese C., Thiel A., Tillmann R.L., Ditt V., Muller A., Schildgen O., Schildgen V. High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin. Vaccine Immunol. 2010, 17:481-484.
34. Manoha C., Espinosa S., Aho S.L., Huet F., Pothier P. Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J. Clin. Virol. 2007, 38:221-226.
35. Martin E.T., Kuypers J., Heugel J., Englund J.A. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn. Microbiol. Infect. Dis. 2008, 62:382-388.
36. Merkel OM, Kissel T. Nonviral pulmonary delivery of siRNA. Acc. Chem. Res., in press.
37. Moschos S.A., Frick M., Taylor B., Turnpenny P., Graves H., Spink K.G., Brady K., Lamb D., Collins D., Rockel T.D., Weber M., Lazari O., Perez-Tosar L., Fancy S.A., Lapthorn C., Green M.X., Evans S., Selby M., Jones G., Jones L., Kearney S., Mechiche H., Gikunju D., Subramanian R., Uhlmann E., Jurk M., Vollmer J., Ciaramella G., Yeadon Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Mol. Ther. 2011, 19:2163-2168.
38. Peiris J.S., Tang W.H., Chan K.H., Khong P.L., Guan Y., Lau Y.L., Chiu S.S. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg. Infect. Dis. 2003, 9:628-633.
39. Prakash T.P., Allerson C.R., Dande P., Vickers T.A., Sioufi N., Jarres R., Baker B.F., Swayze E.E., Griffey R.H., Bhat B. Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 2005, 48:4247-4253.
40. Raemdonck K., Vandenbroucke R.E., Demeester J., Sanders N.N., De Smedt S.C. Maintaining the silence. reflections on long-term RNAi. Drug Discov. Today 2008, 13:917-931.
41. Raza K., Ismailjee S.B., Crespo M., Studer S.M., Sanghavi S., Paterson D.L., Kwak E.J., Rinaldo C.R., Pilewski J.M., McCurry K.R., Husain S. Successful outcome of human metapneumovirus hMPV pneumonia in a lung transplant recipient treated with intravenous ribavirin. J. Heart Lung Transplant. 2007, 26:862-864.
42. Rose S.D., Kim D.H., Amarzguioui M., Heidel J.D., Collingwood M.A., Davis M.E., Rossi J.J., Behlke M.A. Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res. 2005, 33:4140-4156.
43. Saberi M., Bjelica D., Schenk S., Imamura T., Bandyopadhyay G., Li P., Vargeese C., Wang W., Bowman K., Zhang Y., Polisky B., Olefsky J.M. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1137-E1146.
44. Saravolac E.G., Wong J.P., Cairns M.J. Recent patents in antiviral siRNAs. Recent Pat. Antiinfect. Drug Discov. 2010, 5:44-57.
45. Schildgen V., Lüsebrink J., Ditt V., Tillmann R., Simon A., Muller A., Schildgen O. Human HepG2 cells support respiratory syncytial virus and human metapneumovirus replication. J. Virol. Methods 2010, 163:74-81.
46. Sharp P.A. RNAi and double-strand RNA. Genes Dev. 1999, 13:139-141.
47. Sontheimer E.J. Assembly and function of RNA silencing complexes. Nat. Rev. Mol. Cell Biol. 2005, 6:127-138.
48. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., Elbashir S., Geick A., Hadwiger P., Harborth J., John M., Kesavan V., Lavine G., Pandey R.K., Racie T., Rajeev K.G., Rohl I., Toudjarska I., Wang G., Wuschko S., Bumcrot D., Koteliansky V., Limmer S., Manoharan M., Vornlocher H.P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178.
49. Stockton J., Stephenson I., Fleming D., Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg. Infect. Dis. 2002, 8:897-901.
50. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., Osterhaus A.D. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 2001, 7:719-724.
51. Volloch V., Schweitzer B., Rits S. Ligation-mediated amplification of RNA from murine erythroid cells reveals a novel class of beta globin mRNA with an extended 5'-untranslated region. Nucleic Acids Res. 1994, 22:2507-2511.
52. Walsh E.E., Peterson D.R., Falsey A.R. Human metapneumovirus infections in adults: another piece of the puzzle. Arch. Intern. Med. 2008, 168:2489-2496.
53. Williams J.V., Harris P.A., Tollefson S.J., Halburnt-Rush L.L., Pingsterhaus J.M., Edwards K.M., Wright P.F., Crowe J.E. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 2004, 350:443-450.
54. Zhang W., Yang H., Kong X., Mohapatra S., San Juan-Vergara H., Hellermann G., Behera S., Singam R., Lockey R.F., Mohapatra S.S. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 2005, 11:56-62.
55. Zhou H., Jin M., Yu Z., Xu X., Peng Y., Wu H., Liu J., Liu H., Cao S., Chen H. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice. Antiviral Res. 2007, 76:186-193.